BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 22404629)

  • 21. [Production of bacteriocins by gram-positive bacteria and the mechanisms of transcriptional regulation].
    Kotel'nikova EA; Gel'fand MS
    Genetika; 2002 Jun; 38(6):758-72. PubMed ID: 12138775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic charting of ribosomally synthesized natural product chemical space facilitates targeted mining.
    Skinnider MA; Johnston CW; Edgar RE; Dejong CA; Merwin NJ; Rees PN; Magarvey NA
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6343-E6351. PubMed ID: 27698135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peptide signal molecules and bacteriocins in Gram-negative bacteria: a genome-wide in silico screening for peptides containing a double-glycine leader sequence and their cognate transporters.
    Dirix G; Monsieurs P; Dombrecht B; Daniels R; Marchal K; Vanderleyden J; Michiels J
    Peptides; 2004 Sep; 25(9):1425-40. PubMed ID: 15374646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospecting genomes for lasso peptides.
    Maksimov MO; Link AJ
    J Ind Microbiol Biotechnol; 2014 Feb; 41(2):333-44. PubMed ID: 24142336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insights into the Biosynthesis of Duramycin.
    Huo L; Ökesli A; Zhao M; van der Donk WA
    Appl Environ Microbiol; 2017 Feb; 83(3):. PubMed ID: 27864176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes.
    Repka LM; Chekan JR; Nair SK; van der Donk WA
    Chem Rev; 2017 Apr; 117(8):5457-5520. PubMed ID: 28135077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lasso peptides: an intriguing class of bacterial natural products.
    Hegemann JD; Zimmermann M; Xie X; Marahiel MA
    Acc Chem Res; 2015 Jul; 48(7):1909-19. PubMed ID: 26079760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Capture of micrococcin biosynthetic intermediates reveals C-terminal processing as an obligatory step for in vivo maturation.
    Bewley KD; Bennallack PR; Burlingame MA; Robison RA; Griffitts JS; Miller SM
    Proc Natl Acad Sci U S A; 2016 Nov; 113(44):12450-12455. PubMed ID: 27791142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification of antilisterial bacteriocins.
    Berjeaud JM; Cenatiempo Y
    Methods Mol Biol; 2004; 268():225-33. PubMed ID: 15156034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The dawning of a 'Golden era' in lantibiotic bioengineering.
    Field D; Hill C; Cotter PD; Ross RP
    Mol Microbiol; 2010 Dec; 78(5):1077-87. PubMed ID: 21091497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of lantipeptides in Escherichia coli.
    Shi Y; Yang X; Garg N; van der Donk WA
    J Am Chem Soc; 2011 Mar; 133(8):2338-41. PubMed ID: 21114289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biosynthesis of aminovinyl-cysteine-containing peptides and its application in the production of potential drug candidates.
    Sit CS; Yoganathan S; Vederas JC
    Acc Chem Res; 2011 Apr; 44(4):261-8. PubMed ID: 21366289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-molecular-weight post-translationally modified microcins.
    Severinov K; Semenova E; Kazakov A; Kazakov T; Gelfand MS
    Mol Microbiol; 2007 Sep; 65(6):1380-94. PubMed ID: 17711420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Posttranslationally modified bacteriocins--the lantibiotics.
    Guder A; Wiedemann I; Sahl HG
    Biopolymers; 2000; 55(1):62-73. PubMed ID: 10931442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biosynthesis: Leading the way to RiPPs.
    Link AJ
    Nat Chem Biol; 2015 Aug; 11(8):551-2. PubMed ID: 26196773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two-peptide bacteriocins produced by lactic acid bacteria.
    Garneau S; Martin NI; Vederas JC
    Biochimie; 2002; 84(5-6):577-92. PubMed ID: 12423802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lantibiotic engineering: molecular characterization and exploitation of lantibiotic-synthesizing enzymes for peptide engineering.
    Nagao J; Aso Y; Shioya K; Nakayama J; Sonomoto K
    J Mol Microbiol Biotechnol; 2007; 13(4):235-42. PubMed ID: 17827974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New developments in RiPP discovery, enzymology and engineering.
    Montalbán-López M; Scott TA; Ramesh S; Rahman IR; van Heel AJ; Viel JH; Bandarian V; Dittmann E; Genilloud O; Goto Y; Grande Burgos MJ; Hill C; Kim S; Koehnke J; Latham JA; Link AJ; Martínez B; Nair SK; Nicolet Y; Rebuffat S; Sahl HG; Sareen D; Schmidt EW; Schmitt L; Severinov K; Süssmuth RD; Truman AW; Wang H; Weng JK; van Wezel GP; Zhang Q; Zhong J; Piel J; Mitchell DA; Kuipers OP; van der Donk WA
    Nat Prod Rep; 2021 Jan; 38(1):130-239. PubMed ID: 32935693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Posttranslationally modified microcins].
    Pavlova OA; Severinov KV
    Genetika; 2006 Dec; 42(12):1636-46. PubMed ID: 17326383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The expanding structural variety among bacteriocins from Gram-positive bacteria.
    Acedo JZ; Chiorean S; Vederas JC; van Belkum MJ
    FEMS Microbiol Rev; 2018 Nov; 42(6):805-828. PubMed ID: 30085042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.